See exactly how we proved it.

Capital file issued

Situation

SFU VentureLabs brought a science and deeptech cohort of 39 companies in for economic value added and capital readiness.

Ask

Give founders, investors, the accelerator, and public reviewers a capital picture that goes past jobs, projects, and revenue.

What we did

Each company: a five-year path, capital efficiency, and funding velocity. The cohort: economic value added — profit after a charge for the capital employed — plus capital efficiency, funding velocity, R&D capital health, and capital resilience, set against British Columbia, Canada, and the United States.

Outcome

• Founders and CEOs have a true view of financial impact. • Investors can find the companies and read how capital was used. • VentureLabs has an impact report past jobs, projects, and revenue. • Government and industry bodies have a cohort they can extend beyond these 39.

Limit progression stopped

Situation

Global specialty-products distributor, $800M+ revenue, audited annual statements, being evaluated for a new credit line.

Ask

Confirm debt-service capacity ahead of a credit committee decision.

What we did

Reconciled the three primary statements against debt, lease, interest and impairment disclosures, then reconstructed a preliminary adjusted-EBITDA bridge to test coverage against reported cash interest. Held for human sign-off before release.

Outcome

~0.5x EBITDA interest coverage, ~0.1x operating-cash-flow coverage, >20x preliminary leverage. Automatic limit progression stopped; downside case required before committee review.

Cash conversion not durable

Situation

Regional technology distributor, audited annual statements, reporting strong positive operating cash flow.

Ask

Confirm whether cash conversion was durable enough to underwrite a receivables/payables financing facility.

What we did

Reconciled reported operating cash flow to underlying working-capital movements, isolated supplier-payables growth as a sensitivity, and calculated supplier concentration from the payables schedule.

Outcome

Reported +3.5B (local currency) operating cash flow reversed to ~(1.8B) once supplier-payables growth was excluded; one supplier held >75% of trade payables.

Trust Link™ activated

Situation

AI robotics company, post Series B, on an institutional-growth path. Named on FT Americas’ Fastest Growing Companies for a fifth consecutive year, and on the Deloitte Technology Fast 500™.

Ask

Activate Trust Link™ as the verified financial identity for institutional counterparties.

What we did

Built and activated Trust Link™ on the verified file. The exact valuation is confidential; the published floor is USD $350M+.

Outcome

Trust Link™ activated. USD $350M+ (exact figure confidential).

Trust Link™ activated

Situation

North American HealthTech / AI company, Series A, $21M, requiring a verified identity plus the operating stack behind it.

Ask

Activate Trust Link™, with QuantVal™, QuantCore™, and QuantShield™ on the same file.

What we did

QuantVal™ valuation, QuantCore™ operating file, and QuantShield™, then Trust Link™ activation after human sign-off.

Outcome

Trust Link™ activated. Standard QuantVal™, QuantCore™, and QuantShield™ output delivered. The company raised $1.5M from Pacifican. When the Government of Canada committed $1.5M in federal capital as part of a $17.3M package to BC tech companies, the decision rested on three things: verified financials, defensible IP, and a credible commercialization path — the same three conditions Trust Link™ tests on every engagement.

Valuation input rejected

Situation

Western European technology-services company, ~€90M reported revenue, audited statements spanning unequal periods.

Ask

Establish a defensible organic-growth rate for valuation and peer comparison.

What we did

Detected a 15-month current period against a 12-month comparator, ran a duration-only normalization, and flagged a concurrent merger and receivables financing as further comparability factors.

Outcome

Headline growth above 50% fell to the low-20s on duration alone — rejected as a valuation input pending a management-approved pro-forma bridge.

Held pending source ledger

Situation

East Asian technology distributor, non-English audited statements plus a subsequent management balance sheet.

Ask

Confirm audited-to-management equity continuity for ongoing portfolio monitoring.

What we did

Standardized the non-English statements while preserving original-currency lineage, matched audited comparative equity to the management opening position, and rebuilt the retained-earnings movement.

Outcome

A 0.55B (local currency) gap remained between the retained-earnings movement and management-period net income — held pending source-ledger evidence, not forced to balance.

Still negative

Situation

North American technology platform and reseller, $250M+ revenue, unaudited financial workbook.

Ask

Establish quality of earnings and normalized cash flow ahead of a transaction.

What we did

Traced depreciation and amortization through the operating and investing sections, built a preliminary noncash normalization, and connected the reclassification to goodwill exposure.

Outcome

A $5.5M reclassification narrowed reported operating cash outflow from ~$6.9M to a preliminary ~$1.4M — still negative, with ~$45M of goodwill remaining valuation-sensitive.

Converted to credit condition

Situation

North American IT solutions provider, $20M+ revenue, preliminary unaudited statements with no cash-flow statement supplied.

Ask

Assess whether reported owner distributions were consistent with the company's liquidity position.

What we did

Compared reported distributions with year-end equity and the period's loss, then tested whether the package could establish timing, authorization or cash settlement.

Outcome

Distributions exceeded $20M — more than 3.7x year-end equity during a loss year — converted into a formal credit condition requiring an equity roll-forward and cash evidence.

Decision-incomplete

Situation

East Asian large-scale technology distributor, multi-billion-revenue equivalent, three-statement package with no notes or audit opinion.

Ask

Determine whether a reconciled statement package was sufficient to support a credit decision.

What we did

Reconciled the three primary statements, including the cash roll-forward within published rounding, and separated mathematical agreement from evidence completeness.

Outcome

The package passed reconciliation but was held as decision-incomplete — notes, audit status, debt schedules and concentration data still required.

IPO valuation issued

Situation

Professional soccer club with 50 million fans, preparing an IPO file.

Ask

Independent QuantVal™ valuation the offering could take to market.

What we did

QuantVal™ multi-method valuation of the club, held for human sign-off before release into the IPO workstream.

Outcome

USD $295M valuation delivered into the IPO process.

IPO valuation issued

Situation

Professional soccer club with 35 million fans, preparing an IPO file.

Ask

Independent QuantVal™ valuation the offering could take to market.

What we did

QuantVal™ multi-method valuation of the club, held for human sign-off before release into the IPO workstream.

Outcome

USD $230M valuation delivered into the IPO process.

Delivered to the bank

Situation

International transport and shipping company preparing for IPO, with an investment bank running the offering.

Ask

Independent QuantVal™ valuation the bank could put in the IPO file.

What we did

QuantVal™ valuation for the investment bank’s IPO workstream, held for human sign-off before release.

Outcome

Valuation delivered into the IPO process. The bank used the QuantVal™ output in the offering file.

Valuation issued

Situation

Food-industry producer of canned fish, requiring an independent valuation.

Ask

QuantVal™ valuation stated as a figure the file could carry.

What we did

QuantVal™ multi-method valuation of the business, held for human sign-off before release.

Outcome

USD $23M valuation delivered.

Trust Link™ activated

Situation

NellaDerm Therapeutics Inc. is a precision-dermatology company for chronic inflammatory skin diseases, initially atopic dermatitis. Commercial products: NovaNella Balm and NellaCalm Face Cream.

Ask

Activate Trust Link™ as the verified financial identity.

What we did

Built and activated Trust Link™ on the verified file, held for human sign-off before release.

Outcome

Trust Link™ activated.

Trust Link™ activated

Situation

SpamKill Inc. Invisible form-spam protection that analyzes behavior rather than content — no CAPTCHA. 1,500+ businesses protected, 100M+ submissions filtered, 99.9% detection accuracy.

Ask

Independent QuantVal™ valuation and Trust Link™ activation.

What we did

QuantVal™ multi-method valuation of the business, then Trust Link™ activation after human sign-off.

Outcome

QuantVal™ issued. Trust Link™ activated.

Valuation issued

Situation

siift ai inc. Agentic AI operating system for building a business — an executive filter that helps founders ideate, validate, go to market, and scale, used by 1,200+ builders.

Ask

Independent QuantVal™ valuation the file could carry.

What we did

QuantVal™ multi-method valuation of the business, held for human sign-off before release.

Outcome

QuantVal™ valuation delivered.